2014 CMHC - Professional Education (non-CME)

Wednesday - Thursday - View Program Agenda

Round out your CMHC educational experience by attending Professional Education symposia focused on novel therapies and diagnostic testing. These non-certified activities are not part of the official CMHC program and are planned solely by the sponsoring organizations/companies. There are no fees to attend and meals or refreshments may be provided. Register for the CMHC today to sign up for these activities.

Wednesday, October 22, 2014 · Professional Education (non-CME)

11:15am - 12:30pm Symposium (non-CME) The Effect of a Once-Weekly Therapy on A1C and
Weight Over 3 Years
Sponsored by AstraZeneca Diabetes
Neil I. Kaminsky, MD
12:30pm - 2:00pm Symposium (non-CME)
Advancing Paradigm Changes in Type 2 Diabetes Management
Sponsored by Janssen Pharmaceuticals, Inc.
Robert Busch, MD
2:00pm - 3:15pm Symposium (non-CME)
Addressing Chronic Weight Management with Targeted Pharmacotherapy
Sponsored by Eisai, Inc.
Harold E. Bays, MD
3:15pm - 4:30pm Symposium (non-CME)
Understanding High Triglycerides
Sponsored by AstraZeneca
JoAnne M. Foody, MD
4:30pm - 5:45pm Symposium (non-CME)
SGLT2 Inhibition: A Glucuretic Treatment Option for Your Adult Patients With Type 2 Diabetes
Sponsored by AstraZeneca Diabetes
Neil I. Kaminsky, MD
5:45pm - 7:00pm Symposium (non-CME)
Chronic Weight Management in Adults: A Treatment Option
Sponsored by Takeda Pharmaceuticals America, Inc.
Harold E. Bays, MD
7:00pm - 8:30pm Symposium (non-CME)
New Diagnostic Tools for the Prevention and Comprehensive
Management of Diabetes
Sponsored by Health Diagnostic Laboratory, Inc.
Timothy E. Graham, MD

Friday, October 24, 2014 · Professional Education (non-CME)

6:00pm - 7:00pm Symposium A (non-CME)
Take a Closer Look at Homozygous Familial Hypercholesterolemia
Sponsored by Aegerion Pharmaceuticals
Daniel Wise, MD
6:00pm - 7:00pm Symposium B (non-CME)
Treatment Considerations for Generalized Lipodystrophy
Sponsored by AstraZeneca
Jean Chan, MD

Note: Agenda & Faculty are subject to change.